Maxonis
Business Services · 1-10 Employees
View Company Info for Free
Overview
Website
www.maxonis.comRevenue
<$5 MillionIndustry
About Maxonis
Maxonis specializes in revolutionary nerve repair solutions, focusing on the treatment of neuronal injuries in both the peripheral and central nervous systems. Their flagship product, LDP-916, is a first-in-class peptide hydrogel therapy designed to regenerate nerve tissue and restore function in patients suffering from Peripheral Nerve Injury (PNI) and Spinal Cord Injury (SCI). The company aims to address significant unmet medical needs, providing innovative therapies that activate natural nerve repair pathways and support guided regeneration. Maxonis is open to collaboration with clinicians, researchers, and strategic partners to further advance their groundbreaking technology.Explore more
Maxonis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Maxonis Tech Stack
A closer look at the technologies used by Maxonis
See more technologies
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Maxonis
Sign Up For FreeTo access detailed company insights
Maxonis specializes in revolutionary nerve repair solutions, focusing on the treatment of neuronal injuries in both the peripheral and central nervous systems. Their flagship product, LDP-916, is a first-in-class peptide hydrogel therapy designed to regenerate nerve tissue and restore function in patients suffering from Peripheral Nerve Injury (PNI... Read More
